• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型戈谢病:通过CT和闪烁扫描评估骨骼受累情况。

Gaucher's disease type 1: assessment of bone involvement by CT and scintigraphy.

作者信息

Hermann G, Goldblatt J, Levy R N, Goldsmith S J, Desnick R J, Grabowski G A

出版信息

AJR Am J Roentgenol. 1986 Nov;147(5):943-8. doi: 10.2214/ajr.147.5.943.

DOI:10.2214/ajr.147.5.943
PMID:3490167
Abstract

The effectiveness of CT and technetium-99m sulfur colloid (99mTc SC) bone-marrow scans in determining the extent and severity of skeletal involvement in 23 patients with type 1 Gaucher's disease was compared with the effectiveness of conventional radiographic techniques and technetium-99m methylene diphosphonate (99mTc MDP) bone scintigrams. Density measurements obtained by CT proved sensitive in differentiating normal marrow (-50 to -120 H). Scintigrams with the sulfur colloid nuclide demonstrated three distinct patterns of uptake: peripheral expansion of normal marrow (profile B), greater marrow expansion with patchy areas lacking uptake (profile C), and greater loss of uptake with retention of the nuclide in other reticuloendothelial organs and circulation (profile D). CT scans provided greater sensitivity in resolving the extent of marrow involvement in affected areas, while the 99mTc SC scintigrams were more effective in overall assessment of the severity of bone-marrow involvement. Both conventional radiographic techniques and 99mTc MDP bone scans were useful primarily as screening procedures or for evaluating specific involved areas. 99mTc MDP scans were useful in evaluating regional defects (i.e., ischemic necrosis) in certain cases, but no consistent patterns were observed. CT and 99mTc SC scans are useful for determining the extent and severity of Gaucher's disease involvement of bone marrow.

摘要

对23例1型戈谢病患者,比较了CT和锝-99m硫胶体(99mTc SC)骨髓扫描在确定骨骼受累范围和严重程度方面的有效性,并与传统放射学技术和锝-99m亚甲基二膦酸盐(99mTc MDP)骨扫描的有效性进行了比较。CT获得的密度测量结果被证明对区分正常骨髓(-50至-120 H)很敏感。硫胶体核素的扫描显示出三种不同的摄取模式:正常骨髓的外周扩张(B型)、骨髓扩张更明显且有摄取缺失的斑片状区域(C型)以及摄取丧失更严重且核素保留在其他网状内皮器官和循环中的情况(D型)。CT扫描在确定受累区域骨髓受累范围方面具有更高的敏感性,而99mTc SC扫描在全面评估骨髓受累严重程度方面更有效。传统放射学技术和99mTc MDP骨扫描主要作为筛查程序或用于评估特定受累区域。99mTc MDP扫描在某些情况下对评估区域缺损(即缺血性坏死)有用,但未观察到一致的模式。CT和99mTc SC扫描有助于确定戈谢病骨髓受累的范围和严重程度。

相似文献

1
Gaucher's disease type 1: assessment of bone involvement by CT and scintigraphy.1型戈谢病:通过CT和闪烁扫描评估骨骼受累情况。
AJR Am J Roentgenol. 1986 Nov;147(5):943-8. doi: 10.2214/ajr.147.5.943.
2
Severity of bone marrow involvement in patients with Gaucher's disease evaluated by scintigraphy with 99mTc-sestamibi.用99mTc-司他米比闪烁显像评估戈谢病患者骨髓受累的严重程度。
J Nucl Med. 2003 Aug;44(8):1253-62.
3
Scintigraphic findings on 99mTc-MDP, 99mTc-sestamibi and 99mTc-HMPAO images in Gaucher's disease.戈谢病患者99mTc-MDP、99mTc-司他米比和99mTc-HMPAO图像的闪烁扫描结果。
Eur J Nucl Med. 1996 Apr;23(4):466-70. doi: 10.1007/BF01247378.
4
The usefulness of bone-marrow scintigraphy in the detection of bone metastasis from prostatic cancer.
Eur J Nucl Med. 1985;11(8):319-22. doi: 10.1007/BF00252345.
5
The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.高危前列腺癌患者骨转移的检测:99mTc-MDP平面骨闪烁显像、单视野和多视野SPECT、18F-氟化物PET以及18F-氟化物PET/CT。
J Nucl Med. 2006 Feb;47(2):287-97.
6
Nuclear Medicine Musculoskeletal Assessment, Protocols, and Interpretation核医学肌肉骨骼评估、协议与解读
7
Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter.I型戈谢病成年患者骨骼受累情况的量化:通过狄克逊定量化学位移成像测量脂肪分数作为有效参数。
AJR Am J Roentgenol. 2002 Oct;179(4):961-5. doi: 10.2214/ajr.179.4.1790961.
8
"Cold bone scans" as a sign of hemorrhagic infarcts of the spine in Gaucher's disease.
Pediatr Radiol. 1997 Jun;27(6):514-6. doi: 10.1007/s002470050170.
9
Scintigraphic findings in Gaucher's disease.
J Nucl Med. 1986 Oct;27(10):1557-63.
10
Bone, bone marrow, and MIBI scintigraphic findings in Gaucher's disease "bone crisis".戈谢病“骨危象”的骨骼、骨髓及甲氧基异丁基异腈闪烁显像结果
Clin Nucl Med. 2001 Sep;26(9):765-9. doi: 10.1097/00003072-200109000-00005.

引用本文的文献

1
Gaucher disease: Basic and translational science needs for more complete therapy and management.戈谢病:实现更全面治疗与管理所需的基础与转化科学
Mol Genet Metab. 2021 Feb;132(2):59-75. doi: 10.1016/j.ymgme.2020.12.291. Epub 2020 Dec 29.
2
Aberrant progranulin, YKL-40, cathepsin D and cathepsin S in Gaucher disease.戈谢氏病中异常的颗粒蛋白聚糖、YKL-40、组织蛋白酶 D 和组织蛋白酶 S。
Mol Genet Metab. 2019 Sep-Oct;128(1-2):62-67. doi: 10.1016/j.ymgme.2019.07.014. Epub 2019 Jul 23.
3
Imaging of Gaucher disease.戈谢病的影像学检查
World J Radiol. 2014 Sep 28;6(9):657-68. doi: 10.4329/wjr.v6.i9.657.
4
Radiological aspects of Gaucher disease.戈谢病的放射学表现。
Skeletal Radiol. 2011 Dec;40(12):1505-13. doi: 10.1007/s00256-010-0992-3. Epub 2010 Jul 25.
5
Review of the safety and efficacy of imiglucerase treatment of Gaucher disease.伊米苷酶治疗戈谢病的安全性与疗效综述。
Biologics. 2009;3:407-17. doi: 10.2147/btt.2009.3497. Epub 2009 Sep 15.
6
The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients.N370S型戈谢病未被充分认识的进展性本质及403例患者癌症风险评估
Am J Hematol. 2009 Apr;84(4):208-14. doi: 10.1002/ajh.21362.
7
Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring.非神经元型戈谢病的管理,特别涉及妊娠、脾切除术、双膦酸盐治疗、生物标志物的使用及骨病监测。
J Inherit Metab Dis. 2008 Jun;31(3):319-36. doi: 10.1007/s10545-008-0779-z. Epub 2008 May 23.
8
Gaucher disease and bone: laboratory and skeletal mineral density variations during a long period of enzyme replacement therapy.戈谢病与骨骼:长期酶替代治疗期间的实验室指标及骨矿物质密度变化
J Inherit Metab Dis. 2005;28(5):723-32. doi: 10.1007/s10545-005-0032-y.
9
Paediatric non-neuronopathic Gaucher disease: recommendations for treatment and monitoring.小儿非神经元型戈谢病:治疗与监测建议
Eur J Pediatr. 2004 Feb;163(2):67-75. doi: 10.1007/s00431-003-1363-z. Epub 2003 Dec 16.
10
Current issues in enzyme therapy for Gaucher disease.戈谢病酶替代疗法的当前问题
Drugs. 1996 Aug;52(2):159-67. doi: 10.2165/00003495-199652020-00001.